NeoCortec and Embit launched the dual-band and dual-mode NeoMesh wireless-network module using LoRa modulation, offering ...

Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as ...

The new BRU-78 Dual Carriage System allows the MQ-9 Reaper to carry two bombs on a single hardpoint, doubling the number of ...

Novo Nordisk already has a fairly well-stocked pipeline of candidates, but one of its near-term hopes – CagriSema, which combines semaglutide with dual amylin and calcitonin receptor agonist ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India after receiving regulatory approval. The launch ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Navitas Semiconductor has announced what it believes are the world’s first production-released 650 V bi-directional GaNFast ...

China's LimX Dynamics launched a versatile bipedal robot last year with modular foot ends to walk or roll around as needed. Now the company has demonstrated its agility chops by having the squat bot ...

While Zepbound has a single main ingredient, CagriSema’s two components can’t be dissolved together, requiring them to be manufactured separately and then delivered with a dual-chambered pen. Novo’s ...

Tris’ drug, known scientifically as cebranopadol, is meant to be a dual-acting painkiller ... is currently contending with this system. Its medicine Journavx, the first of a new class of non-opioid ...